Michael Young, MD
Cardiovascular Disease · Lebanon, NHNPI 1891938395
Payments from drug & device makers
Across 335 payments — averaging $5337.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$1.5M
- Boston Scientific$270K
- Abbott$28K
- Medtronic$11K
- EKOS Corporation$4K
- Inari Medical, Inc.$100
- plus $33 from 2 others
What the payments were for
- Consulting fees$24,35046%
- Speaking & faculty fees$3,4386%
- Travel & lodging$15,40429%
- Food & beverage$10,09219%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 176 | $1,476,488 |
| Boston Scientific | 75 | $269,576 |
| Abbott | 34 | $27,638 |
| Medtronic | 41 | $10,673 |
| EKOS Corporation | 6 | $3,580 |
| Inari Medical, Inc. | 1 | $100 |
| Spectrawave, Inc | 1 | $19 |
| Angiodynamics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$18,009
- COREVALVE EVOLUT R$9,104
- WATCHMAN Access System$5,313
- EKOSONIC$3,956
- EVOQUE$1,345
- WATCHMAN FLX$750
- AMPLATZER$548
- SYMPLICITY G3$415
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$413
- MitraClip$286
- PORTICO$276
- SYNERGY$163
- NAVITOR$150
- CoreValve Evolut$147
- SAPIEN 3 Ultra RESILIA$138
- GENERAL VASCULAR INTERVENTION$132
- FLOWTRIEVER CATHETER, S$100
- CT THROMBECTOMY SYSTEM KIT$100
How this compares
$1,788,088 in reported general payments places this provider in the 95th percentile of 112 cardiovascular disease providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $9,327 |
| Metoprolol Succinate | 28 | $316 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Lebanon
- Kevin KwakuLebanon$235K
- Sijun KimLebanon$199K
- Jonathan WaltmanLebanon$169K
- Ian GilchristLebanon$126K
- Daniel OrourkeLebanon$109K
- Lauren Gilstrap MilleyLebanon$101K
- Shawn AhmadLebanon$71K
- Natalia BerryLebanon$45K
- Merle MyersonLebanon$24K
- Bruce AndrusLebanon$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.